Sex
Visit (Number) vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,223 | 121.9 | ± 85.1 | 104.0 | 0.0 | 584.0 | 293 | 1,516 |
CPAP Titration Visit (CPAP) | 1,065 | 71.5 | ± 72.6 | 49.0 | -2.0 | 643.0 | 451 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 69.0 | ± 77.0 | 43.0 | 0.0 | 605.0 | 637 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 849 | 65.9 | ± 69.8 | 45.0 | 0.0 | 477.0 | 667 | 1,516 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,223 | 121.9 | ± 85.1 | 104.0 | 0.0 | 584.0 | 293 | 1,516 |
Male | 783 | 119.3 | ± 81.3 | 103.0 | 0.0 | 544.0 | 175 | 958 |
Female | 440 | 126.4 | ± 91.6 | 104.0 | 0.0 | 584.0 | 118 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,065 | 71.5 | ± 72.6 | 49.0 | -2.0 | 643.0 | 451 | 1,516 |
Male | 699 | 72.6 | ± 69.9 | 53.0 | -2.0 | 643.0 | 259 | 958 |
Female | 366 | 69.5 | ± 77.6 | 42.0 | 0.0 | 599.0 | 192 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 69.0 | ± 77.0 | 43.0 | 0.0 | 605.0 | 637 | 1,516 |
Male | 572 | 66.7 | ± 68.5 | 46.0 | 0.0 | 453.0 | 386 | 958 |
Female | 307 | 73.3 | ± 90.8 | 34.0 | 0.0 | 605.0 | 251 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 849 | 65.9 | ± 69.8 | 45.0 | 0.0 | 477.0 | 667 | 1,516 |
Male | 552 | 66.0 | ± 67.5 | 48.5 | 0.0 | 477.0 | 406 | 958 |
Female | 297 | 65.7 | ± 74.0 | 38.0 | 0.0 | 390.0 | 261 | 558 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,223 | 121.9 | ± 85.1 | 104.0 | 0.0 | 584.0 | 293 | 1,516 |
Native American | 20 | 109.4 | ± 75.9 | 92.0 | 20.0 | 307.0 | 8 | 28 |
Asian | 73 | 94.2 | ± 69.5 | 79.0 | 0.0 | 342.0 | 16 | 89 |
Black | 120 | 124.6 | ± 84.2 | 106.5 | 0.0 | 485.0 | 52 | 172 |
Hispanic | 84 | 133.0 | ± 95.1 | 109.5 | 0.0 | 584.0 | 32 | 116 |
White | 918 | 123.1 | ± 85.5 | 104.0 | 0.0 | 571.0 | 184 | 1,102 |
Other | 8 | 105.3 | ± 55.8 | 115.0 | 11.0 | 187.0 | 1 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,065 | 71.5 | ± 72.6 | 49.0 | -2.0 | 643.0 | 451 | 1,516 |
Native American | 17 | 59.2 | ± 57.5 | 58.0 | 6.0 | 219.0 | 11 | 28 |
Asian | 60 | 55.9 | ± 61.8 | 36.0 | 0.0 | 274.0 | 29 | 89 |
Black | 97 | 62.9 | ± 80.1 | 40.0 | 0.0 | 643.0 | 75 | 172 |
Hispanic | 72 | 74.4 | ± 74.6 | 60.5 | 1.0 | 439.0 | 44 | 116 |
White | 814 | 73.6 | ± 72.6 | 51.0 | -2.0 | 599.0 | 288 | 1,102 |
Other | 5 | 86.2 | ± 52.6 | 83.0 | 9.0 | 155.0 | 4 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 69.0 | ± 77.0 | 43.0 | 0.0 | 605.0 | 637 | 1,516 |
Native American | 13 | 56.4 | ± 77.3 | 38.0 | 2.0 | 302.0 | 15 | 28 |
Asian | 49 | 43.8 | ± 49.0 | 30.0 | 0.0 | 189.0 | 40 | 89 |
Black | 77 | 52.0 | ± 46.8 | 40.0 | 0.0 | 178.0 | 95 | 172 |
Hispanic | 65 | 86.7 | ± 86.2 | 60.0 | 0.0 | 321.0 | 51 | 116 |
White | 672 | 71.0 | ± 79.8 | 44.0 | 0.0 | 605.0 | 430 | 1,102 |
Other | 3 | 135.3 | ± 80.4 | 118.0 | 65.0 | 223.0 | 6 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Total number of hypopneas: (hypopneas with > 50% flow reduction and without oxygen desaturation threshold used and with or without arousal + hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation or with arousal) from type I polysomnography
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 849 | 65.9 | ± 69.8 | 45.0 | 0.0 | 477.0 | 667 | 1,516 |
Native American | 13 | 56.1 | ± 53.5 | 35.0 | 3.0 | 161.0 | 15 | 28 |
Asian | 50 | 40.9 | ± 45.6 | 20.0 | 0.0 | 185.0 | 39 | 89 |
Black | 75 | 49.5 | ± 51.7 | 34.0 | 0.0 | 255.0 | 97 | 172 |
Hispanic | 61 | 66.9 | ± 61.0 | 49.0 | 0.0 | 221.0 | 55 | 116 |
White | 647 | 69.5 | ± 73.2 | 48.0 | 0.0 | 477.0 | 455 | 1,102 |
Other | 3 | 141.3 | ± 119.4 | 79.0 | 66.0 | 279.0 | 6 | 9 |